β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma

BACKGROUND: The use of β-blockers for the management of hypertension has been recently associated with significant clinical benefits in cancer patients. Herein, we investigated whether β-blockers could be used in combination with chemotherapy for the treatment of neuroblastoma. METHODS: Seven β-bloc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pasquier, E, Street, J, Pouchy, C, Carre, M, Gifford, A J, Murray, J, Norris, M D, Trahair, T, Andre, N, Kavallaris, M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2013
Gaiak:
Translational Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3694229/
https://ncbi.nlm.nih.gov/pubmed/23695022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.205
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak